Spruce Biosciences, Inc. (SPRB)

Spruce Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	90	17	119	26	105	564
Market Cap Growth	395.94%	-85.46%	361.35%	-75.29%	-81.46%	-
Enterprise Value	76	-39	16	-58	19	614
Last Close Price	160.07	31.50	219.75	82.31	334.50	1823.25
PS Ratio	70.28	3.53	11.82	-	-	-
PB Ratio	6.84	0.60	1.56	0.38	0.94	3.78
P/TBV Ratio	6.84	0.60	1.56	0.38	0.94	3.78
EV/Sales Ratio	58.17	-	1.62	-	-	-
Debt / Equity Ratio	0.14	0.10	0.06	0.09	0.06	0.04
Asset Turnover	0.03	0.07	0.11	-	-	-
Quick Ratio	2.03	2.54	3.94	6.35	10.03	16.10
Current Ratio	2.60	2.90	4.18	6.72	10.36	16.43
Return on Equity (ROE)	-133.62%	-100.70%	-66.10%	-51.35%	-32.43%	-40.30%
Return on Assets (ROA)	-65.06%	-47.06%	-34.28%	-27.86%	-18.17%	-21.94%
Return on Capital (ROIC)	-81.34%	-62.28%	-41.68%	-30.67%	-19.21%	-23.36%
Earnings Yield	-53.63%	-305.73%	-40.17%	-178.61%	-40.41%	-5.23%
FCF Yield	-57.09%	-322.61%	-27.90%	-161.25%	-34.37%	-4.89%
Buyback Yield / Dilution	-4.46%	-7.15%	-63.68%	-0.71%	-289.93%	-683.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.